IHAM
SGHT icon

Integral Health Asset Management’s Sight Sciences SGHT Stock Holding History

Integral Health Asset Management’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-425,000
Closed -$3.37M – 108
2025
Q4 		$3.37M Buy
+425,000
New +$2.71M 0.17% 79

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
AP
Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Integral Health Asset Management's SGHT Position: Q1 2026 in Review

Integral Health Asset Management sold out of Sight Sciences (SGHT) in Q1 2026, closing a stake of 425,000 shares — an estimated $3.37M sold.

Integral Health Asset Management first reported a position in SGHT in Q4 2025 and held it in 1 quarter. The position peaked at $3.37M in Q4 2025. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • Integral Health Asset Management reported no remaining Sight Sciences position as of Q1 2026 after selling out during the quarter.
  • Integral Health Asset Management sold 425,000 Sight Sciences shares in Q1 2026, an estimated $3.37M.
  • Integral Health Asset Management first reported a position in Sight Sciences in Q4 2025 and held it in 1 quarter.
  • Integral Health Asset Management's Sight Sciences position peaked at $3.37M in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.